OS THERAPIES INCORPORATED Stock Issued During Period, Shares, Restricted Stock Award, Forfeited
OS THERAPIES INCORPORATED (OSTX) reported Stock Issued During Period, Shares, Restricted Stock Award, Forfeited of 40.00 thousand shares for the 1-month period ending 2023-01-31, per its 10-Q filed 2024-05-20.
Discontinued
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited · last filed 2024-05-20
- 2023-01-31: Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 1 month 40.00K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 1 month |
|---|---|
| 2023-01-31 | 40.00K shares 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |